InvestorsObserver
×
News Home

Is Neximmune Inc (NEXI) a Stock to Watch After Losing -40.13% This Week?

Wednesday, February 07, 2024 03:21 PM | InvestorsObserver Analysts

Mentioned in this article

Is Neximmune Inc (NEXI) a Stock to Watch After Losing -40.13% This Week?

Overall market sentiment has been down on Neximmune Inc (NEXI) stock lately. NEXI receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Neximmune Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on NEXI!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With NEXI Stock Today?

Neximmune Inc (NEXI) stock is down -14.56% while the S&P 500 is up 0.85% as of 3:18 PM on Wednesday, Feb 7. NEXI has fallen -$1.53 from the previous closing price of $10.51 on volume of 144,890 shares. Over the past year the S&P 500 has risen 21.53% while NEXI has fallen -14.48%. NEXI lost -$42.01 per share in the over the last 12 months. To screen for more stocks like Neximmune Inc click here.

More About Neximmune Inc

NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. Click Here to get the full Stock Report for Neximmune Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App